Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2011 11:45 ET | Source: Myrexis, Inc.

Myrexis Announces Corporate Reorganization to Focus on Development Objectives

Internal Resources Realigned to Support Development Strategy Further 20% Reduction in Workforce and $1.8 Million in Annual Cost Reduction SALT LAKE CITY, Nov. 18, 2011 (GLOBE NEWSWIRE) --...
November 14, 2011 09:05 ET | Source: Myrexis, Inc.

Myrexis Presents at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium

SALT LAKE CITY, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
November 09, 2011 16:11 ET | Source: Myrexis, Inc.

Myrexis Reports First Quarter Fiscal Year 2012 Results

SALT LAKE CITY, Nov. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
November 03, 2011 18:03 ET | Source: Myrexis, Inc.

CORRECTION -- Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results

SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- In a press release issued earlier today by Myrexis, Inc. (Nasdaq:MYRX) with the same headline, please note that the conference call will be held on...
November 03, 2011 16:02 ET | Source: Myrexis, Inc.

Myrexis to Present at 2011 EORTC/NCI/AACR Molecular Targets and Cancer Therapeutics Symposium

SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
November 03, 2011 16:02 ET | Source: Myrexis, Inc.

Myrexis to Hold Conference Call to Discuss First Quarter 2012 Financial Results

SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
October 20, 2011 16:37 ET | Source: Myrexis, Inc.

Myrexis Appoints Jason M. Aryeh to its Board of Directors

SALT LAKE CITY, Oct. 20, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and...
September 14, 2011 16:00 ET | Source: Myrexis, Inc.

Myrexis to Participate in the 2011 UBS Global Life Sciences Conference

SALT LAKE CITY, Sept. 14, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
September 09, 2011 09:29 ET | Source: Myrexis, Inc.

Myrexis to Present at 2011 Rodman and Renshaw Healthcare Conference

SALT LAKE CITY, Sept. 9, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule compounds with novel chemical structures and...
September 08, 2011 16:02 ET | Source: Myrexis, Inc.

Myrexis Reports Fourth Quarter and Fiscal Year 2011 Results

Clinical Development Strategy Update Conference Call Today at 4:30 pm EDT SALT LAKE CITY, Sept. 8, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right